Study to Investigate Long-Term Safety and Efficacy of GS-100
Project Description:
A Phase 1/2/3 Open-Label, Single Arm, Dose-Finding Study to Investigate Long-Term Safety and Efficacy of GS-100, an Adeno-Associated Virus Serotype 9(AA V9) Vector-Mediated Gene Transfer of Human NGLY, in Patients with NGLY1 Deficiency
Grace Science Foundation
Industry Funded
Co-Investigator, Suter (PI)
01/2024 – present
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation, Continuing Education/Community Training
Target Audience:
Adults with Disabilities, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Other
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A